Nurix Therapeutics CLO sells $134k in stock after option exercise

Chief Legal Officer Christine Ring of Nurix Therapeutics, Inc. sold 5,786 shares of the company's common stock on October 2, 2026. The sale, amounting to $134,148, occurred after she exercised employee stock options. Ms. Ring purchased the options at $8.72 per share, resulting in a total value of $50,453. These shares were sold under a previously adopted Rule 10b5-1 trading plan.

The stock's price per share during the sale ranged from $22.84 to $23.65. Despite the sale, Ms. Ring now directly holds 9,110 shares of Nurix Therapeutics common stock, in addition to 111,251 derivative securities in the form of employee stock options. Analysts remain optimistic about Nurix's growth potential and strategic partnerships, with price targets ranging from $25 to $45.